Results 81 to 90 of about 45,910 (249)

Pemphigus Vulgaris and Bullous Pemphigoid: Update on Diagnosis and Treatment

Dermatology Practical & Conceptual, 2020
Autoimmune bullous disorders are a heterogeneous spectrum of skin disorders characterized by the production of autoantibodies against adhesion molecules of the skin. The 2 major groups of diseases are “pemphigus diseases” and “autoimmune bullous diseases
V. Di Lernia, D. Casanova, M. Goldust, C. Ricci   +3 more
semanticscholar   +1 more source

Clinical Characteristics and Risk Factors for Cutaneous Manifestations Associated With Nemolizumab in Atopic Dermatitis: A Multicenter Retrospective Study in Japan

The Journal of Dermatology, EarlyView.
ABSTRACT Nemolizumab, an anti‐interleukin‐31 receptor A monoclonal antibody, has been approved in Japan for treating atopic dermatitis (AD)‐associated pruritus. While it is effective for itch control, nemolizumab‐associated cutaneous adverse events have been increasingly recognized, yet their clinical features remain poorly characterized. In this study,
Wataru Sasaki, Ryo Saito, Kenta Suzuki, Daisuke Watanabe, Masako Minami‐Hori, Hirofumi Kamada, Hiroo Amano, Akihiko Uchiyama, Sei‐ichiro Motegi, Machiko Kamura, Kazunari Sugita, Noriko Kubota, Toshifumi Nomura, Maki Ozawa, Toshiya Takahashi, Takashi Yamakita, Kazumitsu Sugiura, Tetsuharu Ikegami, Ken Igawa, Yuka Kimura, Yoko Kataoka, Ryoichi Kamide, Masakazu Takahashi, Akio Tanaka, Mariko Sugawara‐Mikami   +24 more
wiley   +1 more source

Bullous pemphigoid in younger adults: three case reports [PDF]

, 2011
O penfigoide bolhoso é uma dermatose bolhosa autoimune subepidérmica, mais comumente observada na população idosa (acima dos 70 anos). Autoanticorpos são formados contra antígenos específicos da zona de membrana basal: BP180 e BP230 (proteínas do ...
AOKI, Valéria, SANCHEZ, Ana Paula Galli, TEBCHERANI, Antônio José, XAVIER, Tamar Alencar, ZANELLA, Roberta Richter   +4 more
core   +4 more sources

Rituximab for the Management of an Australian Cohort of Treatment Refractory Mucous Membrane Pemphigoid

Australasian Journal of Dermatology, EarlyView.
ABSTRACT Background Mucous membrane pemphigoid (MMP) has a broad range of clinical manifestations, from relatively benign self‐limiting oral lesions to significant scarring (cicatrizing) of the oral, nasal and ocular tissues with severe functional impairment and morbidity.
Bronte Jeffrey, Mark Schifter, Elizabeth Arena, Emily Sullivan, Stephanie Rose, David Joo, David Campbell, Suzanne Culican, David McDonald, Ming Wei Lin   +9 more
wiley   +1 more source

Metronidazole-Induced Bullous Pemphigoid: A Case Report [PDF]

Journal of Clinical and Diagnostic Research, 2015
Bullous pemphigoid is an autoimmune cutaneous blistering disorder, the exact pathogenesis of which is still not fully elucidated. Drug-induced bullous pemphigoid eruptions are rare but have been reported earlier with the use of frusemide, psoralens ...
Saibal Moitra, Sukanta Sen, Indranil Banerjee, Ayan Sikder, Prasanta Das   +4 more
doaj   +1 more source

Case Report: Variety of Target Antigens During 1 Year Follow-Up of a Patient Initially Diagnosed With Bullous Pemphigoid

Frontiers in Immunology, 2022
Autoimmune bullous diseases (AIBDs), presenting cutaneous and/or mucosal bullous lesions, are classified into pemphigus and pemphigoid diseases. A longtime observation for complicated AIBD cases is rarely reported.
Hua Qian, Zhijun Zhou, Luhuai Shi, Huicheng Li, Weijun Liu, Yong Ai, Yangmin Gao, Suying Feng, Takashi Hashimoto, Xiaoguang Li   +9 more
doaj   +1 more source

Incidence, prevalence and mortality of bullous pemphigoid in England 1998–2017: a population‐based cohort study *

British Journal of Dermatology, 2020
A rising incidence and high mortality were found for bullous pemphigoid (BP) over a decade ago in the UK. Updated estimates of its epidemiology are required to understand the healthcare needs of an ageing population.
M. Persson, K. Harman, Y. Vinogradova, S. Langan, J. Hippisley-Cox, K. Thomas, S. Gran   +6 more
semanticscholar   +1 more source

The value of the pragmatic-explanatory continuum indicator summary wheel in an ongoing study: the bullous pemphigoid steroids and tetracyclines study [PDF]

, 2012
BACKGROUND: The Pragmatic-Explanatory Continuum Indicator Summary (PRECIS) tool is intended to be used in the design phase of trials to help investigative teams design trials in-line with their purpose.
Andrew J Nunn, Anna Sandell, Daniel J Bratton, DJ Bratton, DL Riddle, Fenella Wojnarowska, G Tosh, Gudula Kirtschig, Hywel C Williams, KE Thorpe, M Zwarenstein, P Joly, P Joly, RB D'Agostino, RE Glasgow, T Koppenaal   +15 more
core   +2 more sources

Systemic Implications of Bullous Pemphigoid: Bridging Dermatology and Internal Medicine

Diagnostics
Background: Bullous pemphigoid is an autoimmune bullous disease that frequently affects a large skin surface area, but it can also present in localized areas.
Emi Mashima, Natsuko Saito-Sasaki, Yu Sawada   +2 more
doaj   +1 more source

Prevalence and treatment patterns of psoriatic arthritis in the UK.

, 2012
OBJECTIVES: The objectives of this study were to determine the prevalence of PsA in The Health Improvement Network (THIN), a large population-based medical records database in the UK, to examine factors associated with prevalent PsA among patients with ...
A. Ogdie, A. Troxel, Alamanos, Bateman, Chisholm, D. Shin, de Lusignan, Elkayam, Gladman, Gladman, H. Choi, Hollowell, J. M. Gelfand, K. Haynes, Khan, Langham, Lewis, Lewis, Love, Madland, N. N. Mehta, N. Seminara, NIGROVIC, Ogdie, Reich, S. Langan, SCARPA, Seminara, Setty, Shbeeb, Soltani-Arabshahi, T. Love, Taylor, Zachariae   +33 more
core   +1 more source